25 Posts Not to Miss from ESMO Congress 2026: Day 4
DeLLphi-304 Trial: Tarlatamab Versus Chemotherapy in SCLC
OncoDaily Grand Rounds at ESMO 2026: Bladder Cancer Edition Part 2
Toufic Kachaamy: Neoadjuvant Immunotherapy is Changing Colorectal Cancer Care
Julie Gralow։ ESMO - ASCO Joint Session Explored the Evolving Definition of the Modern Oncologist
Amol Akhade: An Indian Phase III Trial With the Potential to Change Practice in Oral Cavity Cancer
Gilberto Lopes: Key Insights from ESMO 2026
OptiTROP-Breast01 Final Analysis: Sacituzumab Tirumotecan Sustains Overall Survival Benefit in Previously Treated Metastatic Triple-Negative Breast Cancer
